Feb 22, 2017 13:12 pm UTC| Business
RUTHERFORD, N.J., Feb. 22, 2017 -- Cancer Genetics, Inc. (Nasdaq:CGIX) an emerging leader in enabling precision medicine for oncology through the use of molecular markers and information, announced today that it has...
Feb 22, 2017 13:06 pm UTC| Business
CENTENNIAL, Colo., Feb. 22, 2017 -- NioCorp Developments Ltd. (“NioCorp” or the “Company”) (TSX:NB)(OTCQX:NIOBF) (FSE:BR3) announces that, further to its existing convertible security facility (the “Convertible...
Feb 22, 2017 13:05 pm UTC| Business
Continues Winning Streak Since 2010 MACAU, Feb. 22, 2017 -- Melco Crown Entertainment Limited (Nasdaq:MPEL) (“Melco Crown Entertainment” or the “Company”), a developer, owner and operator of casino gaming and...
Avid Bioservices to Participate at Upcoming Life Sciences Industry Conferences
Feb 22, 2017 13:05 pm UTC| Business
TUSTIN, Calif., Feb. 22, 2017 -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), today announced that the company will attend and participate at two...
Auris Medical and King's College London Extend Tinnitus Collaboration
Feb 22, 2017 13:02 pm UTC| Business
- Selection of lead compound for AM-102 program planned for 2017 ZUG, Switzerland, Feb. 22, 2017 -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address...
Auris Medical and King's College London Extend Tinnitus Collaboration
Feb 22, 2017 13:02 pm UTC| Business
- Selection of lead compound for AM-102 program planned for 2017 ZUG, Switzerland, Feb. 22, 2017 -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address...
Feb 22, 2017 13:02 pm UTC| Business
WOBURN, Mass., Feb. 22, 2017 -- Aphios® Corporation today announced that it is spinning-off Aphios® Pharma to develop FDA-approved, cannabis-based drugs for treating highly unmet Central Nervous System (CNS) disorders...